Overview Dividends

(AME) Ametek - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0311001004

Instruments,Sensors,Power,Connectors,Motors,Components

AME EPS (Earnings per Share)

EPS Growth (3Y CAGR): 8.24%
EPS Trend (3Y Correlation): 59.9%

AME Revenue

Revenue Growth (3Y CAGR): 5.68%
Revenue Trend (3Y Correlation): 89.3%

Description: AME Ametek September 29, 2025

AMETEK (NYSE:AME) operates two primary divisions: Electronic Instruments Group (EIG) and Electromechanical Group (EMG). The EIG segment supplies advanced instrumentation across process, aerospace, power, and industrial markets, covering everything from oil-and-gas analytical tools to aerospace sensor suites. The EMG segment focuses on engineered medical components, precision motion-control products, specialty metals, and thermal-management systems, and also runs a network of aviation MRO facilities.

In fiscal 2023 the company generated approximately $7.4 billion in revenue, with the EIG division contributing roughly 55 % and EMG the remaining 45 %. Operating margins hovered near 15 %, reflecting strong pricing power in niche aerospace and medical-device markets. Recent quarterly results (Q3-2024) showed earnings per share of $2.10, beating consensus estimates by 8 %.

Key drivers for AMETEK include sustained defense-spending growth (U.S. defense budget up ~5 % YoY), expanding semiconductor capital-expenditure cycles that boost demand for high-precision test equipment, and aging-population trends that underpin medical-device consumption. Conversely, a slowdown in oil-and-gas capital spending could pressure the process-instrument sub-segment. For a deeper quantitative view, you may want to explore ValueRay’s detailed earnings model for AME.

AME Stock Overview

Market Cap in USD	46,678m
Sub-Industry	Electrical Components & Equipment
IPO / Inception	1984-07-19

AME Stock Ratings

Growth Rating	50.9%
Fundamental	74.3%
Dividend Rating	60.6%
Return 12m vs S&P 500	-7.62%
Analyst Rating	4.11 of 5

AME Dividends

Dividend Yield 12m	0.61%
Yield on Cost 5y	1.13%
Annual Growth 5y	11.68%
Payout Consistency	94.3%
Payout Ratio	17.1%

AME Growth Ratios

Growth Correlation 3m	32.1%
Growth Correlation 12m	3.2%
Growth Correlation 5y	89.8%
CAGR 5y	13.89%
CAGR/Max DD 3y (Calmar Ratio)	0.60
CAGR/Mean DD 3y (Pain Ratio)	2.51
Sharpe Ratio 12m	-1.04
Alpha	-13.19
Beta	1.109
Volatility	26.39%
Current Volume	939.5k
Average Volume 20d	1106.8k
Stop Loss	192.1 (-3%)
Signal	1.25

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (1.47b TTM) > 0 and > 6% of Revenue (6% = 429.9m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA -1.26pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 5.75% (prev 11.10%; Δ -5.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.11 (>3.0%) and CFO 1.77b > Net Income 1.47b (YES >=105%, WARN >=100%)

Net Debt (598.9m) to EBITDA (2.05b) ratio: 0.29 <= 3.0 (WARN <= 3.5)

Current Ratio 1.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (231.7m) change vs 12m ago -0.24% (target <= -2.0% for YES)

Gross Margin 36.18% (prev 35.41%; Δ 0.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 46.30% (prev 46.79%; Δ -0.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 17.15 (EBITDA TTM 2.05b / Interest Expense TTM 80.4m) >= 6 (WARN >= 3)

Altman Z'' 6.02

(A) 0.03 = (Total Current Assets 3.06b - Total Current Liabilities 2.65b) / Total Assets 16.18b

(B) 0.74 = Retained Earnings (Balance) 11.92b / Total Assets 16.18b

(D) 2.72 = Book Value of Equity 11.49b / Total Liabilities 4.23b

Total Rating: 6.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 74.28

1. Piotroski 6.50pt = 1.50

2. FCF Yield 3.47% = 1.74

3. FCF Margin 22.93% = 5.73

4. Debt/Equity 0.09 = 2.50

5. Debt/Ebitda 0.29 = 2.43

6. ROIC - WACC (= -0.39)% = -0.48

7. RoE 14.00% = 1.17

8. Rev. Trend 89.26% = 6.69

9. EPS Trend 59.92% = 3.00

What is the price of AME shares?

As of November 05, 2025, the stock is trading at USD 198.06 with a total of 939,466 shares traded.
Over the past week, the price has changed by +7.00%, over one month by +8.24%, over three months by +7.53% and over the past year by +10.81%.

Is Ametek a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Ametek (NYSE:AME) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 74.28 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AME is around 194.14 USD . This means that AME is currently overvalued and has a potential downside of -1.98%.

Is AME a buy, sell or hold?

Ametek has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy AME.

Strong Buy: 10
Buy: 2
Hold: 5
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the AME price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	216.5	9.3%
Analysts Target Price	216.5	9.3%
ValueRay Target Price	219.2	10.7%

AME Fundamental Data Overview November 02, 2025

Market Cap USD = 46.68b (46.68b USD * 1.0 USD.USD)
P/E Trailing = 31.8283
P/E Forward = 24.3902
P/S = 6.5154
P/B = 4.1379
P/EG = 2.692
Beta = 1.109
Revenue TTM = 7.16b USD
EBIT TTM = 1.38b USD
EBITDA TTM = 2.05b USD
Long Term Debt = 1.43b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.04b USD (from shortTermDebt, last quarter)
Debt = 1.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 598.9m USD (from netDebt column, last quarter)
Enterprise Value = 47.28b USD (46.68b + Debt 1.04b - CCE 439.2m)
Interest Coverage Ratio = 17.15 (Ebit TTM 1.38b / Interest Expense TTM 80.4m)
FCF Yield = 3.47% (FCF TTM 1.64b / Enterprise Value 47.28b)
FCF Margin = 22.93% (FCF TTM 1.64b / Revenue TTM 7.16b)
Net Margin = 20.50% (Net Income TTM 1.47b / Revenue TTM 7.16b)
Gross Margin = 36.18% ((Revenue TTM 7.16b - Cost of Revenue TTM 4.57b) / Revenue TTM)
Gross Margin QoQ = 36.25% (prev 35.76%)
Tobins Q-Ratio = 2.92 (Enterprise Value 47.28b / Total Assets 16.18b)
Interest Expense / Debt = 2.17% (Interest Expense 22.5m / Debt 1.04b)
Taxrate = 17.09% (76.5m / 448.0m)
NOPAT = 1.14b (EBIT 1.38b * (1 - 17.09%))
Current Ratio = 1.16 (Total Current Assets 3.06b / Total Current Liabilities 2.65b)
Debt / Equity = 0.09 (Debt 1.04b / totalStockholderEquity, last quarter 11.95b)
Debt / EBITDA = 0.29 (Net Debt 598.9m / EBITDA 2.05b)
Debt / FCF = 0.36 (Net Debt 598.9m / FCF TTM 1.64b)
Total Stockholder Equity = 10.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.08% (Net Income 1.47b / Total Assets 16.18b)
RoE = 14.00% (Net Income TTM 1.47b / Total Stockholder Equity 10.49b)
RoCE = 11.57% (EBIT 1.38b / Capital Employed (Equity 10.49b + L.T.Debt 1.43b))
RoIC = 9.53% (NOPAT 1.14b / Invested Capital 11.99b)
WACC = 9.92% (E(46.68b)/V(47.72b) * Re(10.10%) + D(1.04b)/V(47.72b) * Rd(2.17%) * (1-Tc(0.17)))
Discount Rate = 10.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF Debug] Terminal Value 74.77% ; FCFE base≈1.66b ; Y1≈2.01b ; Y5≈3.31b
Fair Price DCF = 171.9 (DCF Value 39.70b / Shares Outstanding 231.0m; 5y FCF grow 22.85% → 3.0% )
EPS Correlation: 59.92 | EPS CAGR: 8.24% | SUE: 4.0 | # QB: 17
Revenue Correlation: 89.26 | Revenue CAGR: 5.68% | SUE: 2.21 | # QB: 2

Additional Sources for AME Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle